• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchJasper Therapeutics
    Picture of Jasper Therapeutics logo

    JSPR — Jasper Therapeutics News Story

    $0.510.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    • Market Cap
      $16.97m
    • Enterprise Value
      $9.66m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • JSPR Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    JSPR Dividends
    All News

    NASDAQ RESUMED AT 05:45 PM

    Picture of Jasper Therapeutics logoJasper Therapeutics
    16/07/2026 22:45
    NASDAQ RESUMED  AT 05:45 PM

    Recent news on Jasper Therapeutics

    See all news
    • Brief: Jasper Therapeutics Announces Commencement Of An Offer To Purchase Outstanding Warrants

      07/10/2026 13:06
    • Jasper Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary

      14/08/2026 17:20
    • Jasper Therapeutics Q2 loss per share beats estimates, raises $132 mln

      14/08/2026 16:12
    • Jasper Therapeutics, Inc. expected to post a loss of 35 cents a share - Earnings Preview

      07/08/2026 16:01
    • Jasper Therapeutics rises; co announces all-stock merger with Kira Pharma

      16/07/2026 23:05

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.